Karin Hoogendoorn

Biography

Karin Hoogendoorn has more than 20 years of experience within the biotechnology and pharmaceutical industry. Most recently, she served as Associate Director Regulatory CMC in the Cell and Gene therapy unit at Novartis AG where she was in charge of Global Regulatory CMC and overall CMC strategy for cell and gene therapies. She also spent seven years at Janssen Biologics BV (previously Centocor BV) as Associate Director Global Regulatory Affairs-CMC where she was responsible for writing and reviewing quality sections of regulatory dossiers for advanced therapy medicinal products (i.e. cell based medicinal products and combination products) and monoclonal antibodies. In the past, Karin also held different CMC roles at companies such as Crucell Holland BV and OctoPlus Development BV. Karin has a PharmD from Utrecht University, the Netherlands, and holds a MSc in Biology & Bio Pharmaceutical Sciences from Leiden University, the Netherlands. Apart from her role at Immunicum, Karin also serves as Senior Consultant CMC and CMC-RA at Quality RA BV in Leiden, the Netherlands.

Research Interest

biotechnology and pharmaceutical